| Literature DB >> 1585397 |
C R Kehe1, K C Lasseter, N C Miller, K A Wick, E C Shamblen, B P Ekholm, J H Sandahl, S F Chang, M B Goldlust, D C Kvam.
Abstract
The inhalation of atropine sulfate from a pressurized metered-dose inhaler was investigated in a nonrandomized four-period rising-dose study. Eight healthy, nonsmoking subjects received 1.7, 3.4, and 5.2 mg of atropine sulfate by inhalation and 1.67 mg of atropine free base (equivalent to 2 mg of atropine sulfate) by intramuscular (i.m.) injection. Serum atropine sulfate concentrations were measured over a 24-h period by gas chromatography/mass spectrometry. Mean serum concentrations increased nonproportionally as the inhaled dose increased. Mean peak concentrations were 4.9, 6.1, and 7.9 ng/ml for the inhaled doses and 8.4 ng/ml for the i.m. dose. Typical anticholinergic effects were seen after all doses.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1585397 DOI: 10.1097/00007691-199204000-00009
Source DB: PubMed Journal: Ther Drug Monit ISSN: 0163-4356 Impact factor: 3.681